Discover 1,425 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,425
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Tampa FL, Atlanta GA, Homewood AL, Houston TX,
Sponsor: Oncolytics Biotech
Sex: All
Age: 18+
Code: NCT07446322
Phase 2, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Pembroke Pines FL, Hollywood FL, Savannah GA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase 2, Recruiting
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
for
Colorectal Cancer, Gastric Adenocarcinoma,
Location: Tampa FL, Cincinnati OH, Boston MA, Salt Lake City UT,
Sponsor: Dispatch Biotherapeutics
Sex: All
Age: 18+
Code: NCT07544589
Phase 1, Recruiting
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
for
Lymphoma
Location: Tampa FL, Nashville TN, Houston TX, Columbus OH,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT07015242
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Tampa FL, Miami FL, Jacksonville FL, Chapel Hill NC,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07406633
Phase 2, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
for
Gastrointestinal Cancers
Location: Tampa FL, Nashville TN, San Antonio TX, Grand Rapids MI,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07539311
Phase 2, Recruiting
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
for
Small Cell Lung Cancer
Location: Tampa FL, Memphis TN, Fairfax VA, New York NY, Zion IL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07531095
Phase 1, Recruiting
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
Location: Tampa FL, Coral Springs FL, Tamarac FL, Jacksonville FL,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07644559
Phase 2, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Saint Petersburg FL, Tampa FL, Orlando FL,
Location: Sarasota FL, Tampa FL, Safety Harbor FL, Clearwater FL,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
for
Sarcoma, Osteosarcoma
Location: Tampa FL, Columbus OH
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 12 - 40
Code: NCT07725380
Phase 1, Phase 2, Recruiting
L19IL2/TNF in Patients With Basal Cell Carcinoma
for
Locally Advanced Basal Cell Carcinoma
Location: Tampa FL, Atlanta GA, Houston TX
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT07227870
Phase 2, Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Tampa FL, Houston TX, St Louis MO, Zion IL, Goodyear AZ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07594106
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Tampa FL, Atlanta GA, Houston TX, St Louis MO,